NASDAQ : INMD
InMode Ltd. — Key statistics
Healthcare · Medical Devices · Israel
Last price 13.26 USD (Oct 30, 2026, 2:33 PM EDT) · Market cap 762.20M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 759.90M |
| Enterprise Value | 263.23M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 11, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 57.48M |
| Shares Outstanding | 57.48M |
| Shares Change (YoY) | -10.73% |
| Shares Change (QoQ) | -7.14% |
| Owned by Insiders (%) | 13.21% |
| Owned by Institutions (%) | 53.63% |
| Float | 47.94M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 10.86 |
| Forward PE | 10.00 |
| PS Ratio | 2.03 |
| Forward PS | 2.05 |
| PB Ratio | 1.24 |
| P/TBV Ratio | 1.21 |
| P/FCF Ratio | 9.21 |
| P/OCF Ratio | 9.09 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 3.40 |
| EV / Sales | 0.70 |
| EV / EBITDA | 3.70 |
| EV / EBIT | 3.74 |
| EV / FCF | 3.19 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 8.18 |
| Quick Ratio | 6.87 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.06 |
| Debt / FCF | 0.05 |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 12.33% |
| Return on Assets (ROA) | 6.17% |
| Return on Invested Capital (ROIC) | 45.95% |
| Return on Capital Employed (ROCE) | 10.99% |
| Weighted Average Cost of Capital (WACC) | 15.32% |
| Revenue Per Employee | $567,614 |
| Profits Per Employee | $117,445 |
| Employee Count | 660 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 1.26 |
Taxes
| Measure | Value |
|---|
| Income Tax | 13.44M |
| Effective Tax Rate | 14.77% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.03 |
| 52-Week Price Change | -11.39% |
| 50-Day Moving Average | 14.38 |
| 200-Day Moving Average | 14.33 |
| Relative Strength Index (RSI) | 24.15 |
| Average Volume (20 Days) | 467,751 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 2.22M |
| Short Previous Month | 2.25M |
| Short % of Shares Out | 3.86% |
| Short % of Float | 4.63% |
| Short Ratio (days to cover) | 4.73 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 374.63M |
| Gross Profit | 286.68M |
| Operating Income | 70.46M |
| Pretax Income | 90.95M |
| Net Income | 77.51M |
| EBITDA | 71.15M |
| EBIT | 70.46M |
| Earnings Per Share (EPS) | $1.22 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 501.12M |
| Total Debt | 4.45M |
| Net Cash | 496.66M |
| Net Cash Per Share | $8.64 |
| Equity (Book Value) | 629.13M |
| Book Value Per Share | 10.68 |
| Working Capital | 570.56M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 83.58M |
| Capital Expenditures | -1.05M |
| Depreciation & Amortization | 684,000 |
| Net Borrowing | n/a |
| Free Cash Flow | 82.53M |
| FCF Per Share | $1.44 |
Margins
| Measure | Value |
|---|
| Gross Margin | 76.52% |
| Operating Margin | 18.81% |
| Pretax Margin | 24.28% |
| Profit Margin | 20.69% |
| EBITDA Margin | 18.99% |
| EBIT Margin | 18.81% |
| FCF Margin | 22.03% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 10.73% |
| Shareholder Yield | 10.73% |
| Earnings Yield | 9.21% |
| FCF Yield | 10.86% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $16.17 |
| Price Target Difference | 22.32% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 1.60% |
| EPS Growth Forecast (3Y) | -3.27% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Oct 1, 2021 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |